Voie d'immunisation et séquence d'administration de l ... - TEL
Voie d'immunisation et séquence d'administration de l ... - TEL
Voie d'immunisation et séquence d'administration de l ... - TEL
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
tel-00827710, version 1 - 29 May 2013<br />
CD8 + T cell responses are crucial for the <strong>de</strong>fense against many microorganisms and cells<br />
un<strong>de</strong>rgoing malignant transformation. Consequently, in-<strong>de</strong>pth study of CD8 + T cell response<br />
after immunization is critical for un<strong>de</strong>rstanding the mechanisms un<strong>de</strong>rlying the impact of<br />
multiple param<strong>et</strong>ers known to influence immune response, in or<strong>de</strong>r to improve current<br />
vaccination strategies. We initiated our studies by <strong>de</strong>veloping a t<strong>et</strong>ramer-based enrichment<br />
technique that allowed us to carefully analyze the CD8 + T cell response, both phenotypically<br />
and functionally. We then applied these techniques to the in-<strong>de</strong>pth examination of two<br />
param<strong>et</strong>ers that impact immune response: the route of immunization and the timing of<br />
adjuvant <strong>de</strong>livery. In this section, I will first discuss the technical improvement that t<strong>et</strong>ramer-<br />
based enrichment provi<strong>de</strong>s for the study of CD8 + T cells. I will then r<strong>et</strong>urn to a d<strong>et</strong>ailed<br />
discussion of our results, including several hypotheses that could explain why the intra<strong>de</strong>rmal<br />
immunization of cell-associated antigen generated a more robust immune response than<br />
intravenous <strong>de</strong>livery. Finally, I will discuss the results observed regarding the timing of<br />
adjuvant <strong>de</strong>livery and the optimization of treatments that contains a combination of adjuvant<br />
and antigen. I will extend these consi<strong>de</strong>rations to other types of antigen, as well as discuss the<br />
combination of several existing vaccine strategies and the issues raised in terms of the timing<br />
and sequence of administration.<br />
I. TETRAMER-BASED ENRICHMENT: A POWERFUL TOOL<br />
A. Advantages and limitations<br />
1) Sensitivity of the technique<br />
The <strong>de</strong>velopment of t<strong>et</strong>ramer-based enrichment allows for the d<strong>et</strong>ection of rare antigen-<br />
specific CD4 + and CD8 + T cells (Moon <strong>et</strong> al., 2007; Obar <strong>et</strong> al., 2008). This technique allows<br />
for the study of specific T cells in naïve mice and during the first steps of T cell activation<br />
upon immunization without transferring high numbers of TCR-transgenic T cells. The ability<br />
to d<strong>et</strong>ect low numbers of circulating antigen-specific T cells also makes possible to study the<br />
T cell response following a relatively weak antigenic stimulation, which allows for the use of<br />
reduced antigen dose that more accurately reflects a strategy that could be adapted for human<br />
vaccination.<br />
In our studies, the comparison of the intra<strong>de</strong>rmal or intravenous routes of immunization<br />
permitted us to d<strong>et</strong>ermine the outcome of an immune response stimulated by a local versus<br />
systemic dissemination of antigen. As expected, systemically disseminated antigen resulted in<br />
Page 137 of 256